Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;109:234-241
Published online before print December 29, 2003, doi: 10.1161/01.CIR.0000105700.95607.49
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
109/2/234    most recent
01.CIR.0000105700.95607.49v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xing, D.
Right arrow Articles by Oparil, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xing, D.
Right arrow Articles by Oparil, S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ESTRADIOL

(Circulation. 2004;109:234-241.)
© 2004 American Heart Association, Inc.


Basic Science Reports

Estradiol and Progestins Differentially Modulate Leukocyte Infiltration After Vascular Injury

Dongqi Xing, MD, PhD; Andrew Miller, MD; Lea Novak, MD; Ricardo Rocha, MD; Yiu-Fai Chen, PhD; Suzanne Oparil, MD

From the Vascular Biology and Hypertension Program, Division of Cardiovascular Disease, Department of Medicine (D.X., A.M., Y.-F.C., S.O.), and the Division of Transplantation Surgery, Department of Surgery, University of Alabama at Birmingham (L.N.); and Novartis Pharmaceuticals, East Hanover, NJ (R.R.).

Correspondence to Dongqi Xing, MD, PhD, 1014 Zeigler Research Building, University of Alabama at Birmingham, UAB Station, Birmingham, AL 35294. E-mail dqxing{at}uab.edu

Received April 24, 2003; de novo received July 16, 2003; revision received September 11, 2003; accepted September 12, 2003.

Background— Inflammation plays an important role in the response to endoluminal vascular injury. Estrogen (17ß-estradiol, E2) inhibits neointima formation in animal models, and the progestin medroxyprogesterone acetate (MPA) blocks this effect. This study tested the hypothesis that E2 inhibits the migration of inflammatory cells, particularly granulocytes, into the rat carotid arteries after acute endoluminal injury and that MPA blocks this effect.

Methods and Results— Ovariectomized rats were randomly divided into subgroups and treated with E2, MPA, E2+MPA, or vehicle and subjected to balloon injury of the right carotid artery. After 1, 3, or 7 days, rats were euthanized, and carotid arteries (injured and control) were analyzed for inflammatory cells by flow cytometry. At 1 day, granulocytes (HIS48+ and CD45+), monocyte/macrophages (Mar1+ and CD45+), and T lymphocytes (CD3+ and CD45+) were increased 26-fold, 12-fold, and 3-fold, respectively, in injured compared with contralateral control arteries of vehicle-treated rats. Granulocytes and monocyte/macrophages decreased markedly by 3 days. E2 reduced the granulocyte and monocyte/macrophage populations of injured vessels by {approx}50% and increased T lymphocytes. MPA had no independent effect on inflammatory cells but completely blocked the effect of E2. Immunohistochemical examination verified these findings and localized inflammatory cells to the adventitial and periadventitial domains of injured vessels.

Conclusions— E2 may limit the neointimal response to endoluminal vascular injury, at least in part, by limiting leukocyte entry from adventitial/periadventitial tissues into injured vessels early in the injury response.


Key Words: restenosis • inflammation • leukocytes • vessels • women




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Xing, S. Nozell, Y.-F. Chen, F. Hage, and S. Oparil
Estrogen and Mechanisms of Vascular Protection
Arterioscler Thromb Vasc Biol, March 1, 2009; 29(3): 289 - 295.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Xing, W. Feng, L. G. Not, A. P. Miller, Y. Zhang, Y.-F. Chen, E. Majid-Hassan, J. C. Chatham, and S. Oparil
Increased protein O-GlcNAc modification inhibits inflammatory and neointimal responses to acute endoluminal arterial injury
Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H335 - H342.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
I. C Villar, A. J Hobbs, and A. Ahluwalia
Sex differences in vascular function: implication of endothelium-derived hyperpolarizing factor
J. Endocrinol., June 1, 2008; 197(3): 447 - 462.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. A. Booth and B. R. Lucchesi
Medroxyprogesterone acetate prevents the cardioprotective and anti-inflammatory effects of 17beta-estradiol in an in vivo model of myocardial ischemia and reperfusion
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1408 - H1415.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. H. Straub
The Complex Role of Estrogens in Inflammation
Endocr. Rev., August 1, 2007; 28(5): 521 - 574.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. Yuan and J. Xu
Loss-of-Function Deletion of the Steroid Receptor Coactivator-1 Gene in Mice Reduces Estrogen Effect on the Vascular Injury Response
Arterioscler Thromb Vasc Biol, July 1, 2007; 27(7): 1521 - 1527.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Xing, W. Feng, A. P. Miller, N. M. Weathington, Y.-F. Chen, L. Novak, J. E. Blalock, and S. Oparil
Estrogen modulates TNF-{alpha}-induced inflammatory responses in rat aortic smooth muscle cells through estrogen receptor-beta activation
Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2607 - H2612.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. L. Turgeon, M. C. Carr, P. M. Maki, M. E. Mendelsohn, and P. M. Wise
Complex Actions of Sex Steroids in Adipose Tissue, the Cardiovascular System, and Brain: Insights from Basic Science and Clinical Studies
Endocr. Rev., October 1, 2006; 27(6): 575 - 605.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J.-H. Parmentier, C. Zhang, A. Estes, S. Schaefer, and K. U. Malik
Essential role of PKC-{zeta} in normal and angiotensin II-accelerated neointimal growth after vascular injury
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1602 - H1613.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. Sunday, M. M. Tran, D. N. Krause, and S. P. Duckles
Estrogen and progestagens differentially modulate vascular proinflammatory factors
Am J Physiol Endocrinol Metab, August 1, 2006; 291(2): E261 - E267.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Fukushima, S. R. Coppen, A. Varela-Carver, K. Yamahara, P. Sarathchandra, R. T. Smolenski, M. H. Yacoub, and K. Suzuki
A Novel Strategy for Myocardial Protection by Combined Antibody Therapy Inhibiting Both P-Selectin and Intercellular Adhesion Molecule-1 Via Retrograde Intracoronary Route
Circulation, July 4, 2006; 114(1_suppl): I-251 - I-256.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. C. Dimayuga, H. Li, K.-Y. Chyu, G. N. Fredrikson, J. Nilsson, M. C. Fishbein, P. K. Shah, and B. Cercek
T Cell Modulation of Intimal Thickening After Vascular Injury: The Bimodal Role of IFN-{gamma} in Immune Deficiency
Arterioscler Thromb Vasc Biol, December 1, 2005; 25(12): 2528 - 2534.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Okumura, M. Iwai, A. Ide, M. Mogi, M. Ito, and M. Horiuchi
Sex Difference in Vascular Injury and the Vasoprotective Effect of Valsartan Are Related to Differential AT2 Receptor Expression
Hypertension, September 1, 2005; 46(3): 577 - 583.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. A. Yaghini, C. Zhang, J.-H. Parmentier, A. M. Estes, N. Jafari, S. A. Schaefer, and K. U. Malik
Contribution of Arachidonic Acid Metabolites Derived Via Cytochrome P4504A to Angiotensin II-Induced Neointimal Growth
Hypertension, June 1, 2005; 45(6): 1182 - 1187.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Sports. Med.Home page
P M Tiidus
Can oestrogen influence skeletal muscle damage, inflammation, and repair?
Br. J. Sports Med., May 1, 2005; 39(5): 251 - 253.
[Full Text] [PDF]


Home page
EndocrinologyHome page
T. Simoncini, P. Mannella, L. Fornari, A. Caruso, M. Y. Willis, S. Garibaldi, C. Baldacci, and A. R. Genazzani
Differential Signal Transduction of Progesterone and Medroxyprogesterone Acetate in Human Endothelial Cells
Endocrinology, December 1, 2004; 145(12): 5745 - 5756.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Abbas, P. J. Fadel, Z. Wang, D. Arbique, I. Jialal, and W. Vongpatanasin
Contrasting Effects of Oral Versus Transdermal Estrogen on Serum Amyloid A (SAA) and High-Density Lipoprotein-SAA in Postmenopausal Women
Arterioscler Thromb Vasc Biol, October 1, 2004; 24(10): e164 - e167.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. P. Miller, W. Feng, D. Xing, N. M. Weathington, J. E. Blalock, Y.-F. Chen, and S. Oparil
Estrogen Modulates Inflammatory Mediator Expression and Neutrophil Chemotaxis in Injured Arteries
Circulation, September 21, 2004; 110(12): 1664 - 1669.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. K. Bengtsson, E. J. Ryan, D. Giordano, D. M. Magaletti, and E. A. Clark
17{beta}-Estradiol (E2) modulates cytokine and chemokine expression in human monocyte-derived dendritic cells
Blood, September 1, 2004; 104(5): 1404 - 1410.
[Abstract] [Full Text] [PDF]